Wataru Akahata is the founder of VLP Therapeutics. VLP Therapeutics has raised $37M in total funding. Latest round: Series A. Based in Gaithersburg, USA.
Wataru Akahata is the Co-Founder, Chief Executive Officer, and Chief Scientific Officer of VLP Therapeutics, a U.S. biotechnology company. He leads the company's research and development of virus-like particle (VLP) vaccines for infectious diseases and cancer.
Full founder directory · Investor directory · Company funding database · Fundraising library